JAC Advance Access originally published online on February 11, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 545-556
© 2003 The British Society for Antimicrobial Chemotherapy
Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli
Department of Molecular Virology and Microbiology, One Baylor Plaza, Mail-stop: BCM-280, Baylor College of Medicine, Houston, TX 77030-3411, USA
Received 9 April 2002; returned 11 October 2002; revised 13 November 2002; accepted 16 December 2002
Quinolones are widely used, broad-spectrum antimicrobial agents. In screens for genes that, when overexpressed, allow Escherichia coli to grow on otherwise lethal concentrations of the fluoroquinolone norfloxacin, the ydhE gene was identified. We have shown that ydhE encodes a multidrug efflux pump with a narrower substrate range than that of its closest homologue, encoded by norM, and named the gene norE. The relative contributions to drug resistance of NorE compared with the two other known E. coli quinolone pumps, AcrAB and MdfA, have been defined. Overexpression of each of the three pumps separately resulted in roughly similar levels of quinolone resistance, whereas simultaneous overexpression of norE or mdfA in combination with acrAB gave synergic increases in quinolone resistance. The level of quinolone resistance mediated by efflux pumps seems to be constrained to an 
10-fold maximum, even with increased production of the pumps. We measured the drug resistance of an isogenic set of strains containing the various permutations of single, double and triple drug efflux pump mutants. The 
norE and mdfA mutants were somewhat more susceptible to fluoroquinolones than the parent strain, and acrAB mutants were four- to six-fold more susceptible. Mutants lacking two or all three efflux pumps were not significantly more susceptible to fluoroquinolones than those lacking only one of the three pumps.
* This author has previously published as Sonia Rahmati.
Corresponding author. Tel: +1-713-798-5126; Fax: +1-713-798-7375; E-mail: elz{at}bcm.tmc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Long, C. Rouquette-Loughlin, W. M. Shafer, and E. W. Yu Functional Cloning and Characterization of the Multidrug Efflux Pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3052 - 3060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zimhony, I. Chmelnitsky, R. Bardenstein, S. Goland, O. Hammer Muntz, S. Navon Venezia, and Y. Carmeli Endocarditis Caused by Extended-Spectrum-{beta}-Lactamase-Producing Klebsiella pneumoniae: Emergence of Resistance to Ciprofloxacin and Piperacillin-Tazobactam during Treatment despite Initial Susceptibility. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3179 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pumbwe, A. Chang, R. L. Smith, and H. M. Wexler Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates J. Antimicrob. Chemother., September 1, 2006; 58(3): 543 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yang, C. R. Lopez, and E. L. Zechiedrich Quorum sensing and multidrug transporters in Escherichia coli PNAS, February 14, 2006; 103(7): 2386 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Gruger, J. L. Nitiss, A. Maxwell, E. L. Zechiedrich, P. Heisig, S. Seeber, Y. Pommier, and D. Strumberg A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resistance Results in Sensitivity to Drugs Targeting Eukaryotic Topoisomerase II Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4495 - 4504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Eaves, V. Ricci, and L. J. V. Piddock Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica Serovar Typhimurium: Role in Multiple Antibiotic Resistance Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1145 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Komp Lindgren, A. Karlsson, and D. Hughes Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3222 - 3232. [Abstract] [Full Text] [PDF]
|
|